Protara Therapeutics Inc’s filing revealed that its Chf Scientific Operations Off Zummo Jacqueline unloaded Company’s shares for reported $96145.0 on Mar 26 ’25. In the deal valued at $4.53 per share,21,224 shares were sold. As a result of this transaction, Zummo Jacqueline now holds 98,861 shares worth roughly $0.35 million.
Then, Zummo Jacqueline bought 21,224 shares, generating $96,569 in total proceeds.
Before that, Opaleye Management Inc. sold 126,301 shares. Protara Therapeutics Inc shares valued at $215,836 were divested by the 10% Owner at a price of $1.71 per share. As a result of the transaction, Opaleye Management Inc. now holds 45,000 shares, worth roughly $0.16 million.
Scotiabank initiated its Protara Therapeutics Inc [TARA] rating to a Sector outperform in a research note published on April 16, 2025; the price target was $12. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in mid March with a ‘”an Overweight”‘ rating. H.C. Wainwright started covering the stock on June 04, 2021. It rated TARA as “a Buy”.
Price Performance Review of TARA
On Monday, Protara Therapeutics Inc [NASDAQ:TARA] saw its stock fall -18.52% to $3.52. Over the last five days, the stock has lost -8.57%. Protara Therapeutics Inc shares have fallen nearly -33.33% since the year began. Nevertheless, the stocks have risen 24.82% over the past one year. While a 52-week high of $10.48 was reached on 01/06/25, a 52-week low of $1.60 was recorded on 04/28/25. SMA at 50 days reached $4.04, while 200 days put it at $3.34.
Levels Of Support And Resistance For TARA Stock
The 24-hour chart illustrates a support level at 3.06, which if violated will result in even more drops to 2.59. On the upside, there is a resistance level at 4.04. A further resistance level may holdings at 4.55. The Relative Strength Index (RSI) on the 14-day chart is 39.78, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.01, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 72.30%. Stochastics %K at 52.09% indicates the stock is a holding.
How much short interest is there in Protara Therapeutics Inc?
A steep rise in short interest was recorded in Protara Therapeutics Inc stocks on 2025-04-15, growing by 0.25 million shares to a total of 2.03 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 1.78 million shares. There was a rise of 12.23%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 17, 2021 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $43 price target.
